Clinical trial

A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery…

NCT00131898 · Memorial Sloan Kettering Cancer Center, Other · Completed

Key facts

NCT number NCT00131898
Title A Prospective Randomized Trial of Pre-Operative IMRT+Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma
Official title Phase III Prospective Randomized Trial of Pre-Operative Intensity Modulated Radiation Therapy (IMRT) Plus Surgery Versus Surgery Alone For Primary Retroperitoneal Sarcoma
Lead sponsor Memorial Sloan Kettering Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Sarcoma
Intervention type Procedure
Interventions Surgical Resection, Intensity Modulated Radiation Therapy (IMRT)
Enrollment 150
Start date May 1, 2003
Primary completion Sep 1, 2005
Completion Sep 1, 2005
First posted Aug 19, 2005
Last update posted Dec 23, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies